The results showed that high expression of lincFOXF1 (Supplementary Figure 5A, P = 0.000055), NORAD (Supplementary Figure 5C, P = 0.000057) and SBF2-AS1 (Supplementary Figure 5D, P = 0.0003) predicted a better prognosis for HCV-related HCC, while the opposite was true for MALAT1 (Supplementary Figure 5B, P = 0.0066). This evidence concerns the gene NORAD and hepatocellular carcinoma.